Current developments in salivary diagnostics

Craig S. Miller, Joseph D. Foley, Alison L. Bailey, Charles Campbell, Roger L. Humphries, Nicolaos Christodoulides, Pierre N. Floriano, Glennon Simmons, Bryon Bhagwandin, James W. Jacobson, Spencer W. Redding, Jeffrey L. Ebersole, John T. McDevitt

Research output: Contribution to journalReview article

180 Citations (Scopus)

Abstract

Salivary diagnostics is an emerging field that has progressed through several important developments in the past decade, including the publication of the human salivary proteome and the infusion of federal funds to integrate nanotechnologies and microfluidic engineering concepts into developing compact point-of-care devices for rapid analysis of this secretion. In this article, we discuss some of these developments and their relevance to the prognosis, diagnosis and management of periodontitis, as an oral target, and cardiovascular disease, as a systemic example for the potential of these biodiagnostics. Our findings suggest that several biomarkers are associated with distinct biological stages of these diseases and demonstrate promise as practical biomarkers in identifying and managing periodontal disease, and acute myocardial infarction. The majority of these studies have progressed through biomarker discovery, with the identified molecules requiring more robust clinical studies to enable substantive validation for disease diagnosis. It is predicted that with continued advances in this field the use of a combination of biomarkers in multiplex panels is likely to yield accurate screening tools for these diagnoses in the near future.

Original languageEnglish (US)
Pages (from-to)171-189
Number of pages19
JournalBiomarkers in Medicine
Volume4
Issue number1
DOIs
StatePublished - Feb 1 2010
Externally publishedYes

Fingerprint

Biomarkers
Mouth Diseases
Point-of-Care Systems
Nanotechnology
Microfluidics
Periodontitis
Periodontal Diseases
Financial Management
Proteome
Publications
Screening
Cardiovascular Diseases
Myocardial Infarction
Equipment and Supplies
Molecules

All Science Journal Classification (ASJC) codes

  • Drug Discovery
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Miller, C. S., Foley, J. D., Bailey, A. L., Campbell, C., Humphries, R. L., Christodoulides, N., ... McDevitt, J. T. (2010). Current developments in salivary diagnostics. Biomarkers in Medicine, 4(1), 171-189. https://doi.org/10.2217/bmm.09.68

Current developments in salivary diagnostics. / Miller, Craig S.; Foley, Joseph D.; Bailey, Alison L.; Campbell, Charles; Humphries, Roger L.; Christodoulides, Nicolaos; Floriano, Pierre N.; Simmons, Glennon; Bhagwandin, Bryon; Jacobson, James W.; Redding, Spencer W.; Ebersole, Jeffrey L.; McDevitt, John T.

In: Biomarkers in Medicine, Vol. 4, No. 1, 01.02.2010, p. 171-189.

Research output: Contribution to journalReview article

Miller, CS, Foley, JD, Bailey, AL, Campbell, C, Humphries, RL, Christodoulides, N, Floriano, PN, Simmons, G, Bhagwandin, B, Jacobson, JW, Redding, SW, Ebersole, JL & McDevitt, JT 2010, 'Current developments in salivary diagnostics', Biomarkers in Medicine, vol. 4, no. 1, pp. 171-189. https://doi.org/10.2217/bmm.09.68
Miller CS, Foley JD, Bailey AL, Campbell C, Humphries RL, Christodoulides N et al. Current developments in salivary diagnostics. Biomarkers in Medicine. 2010 Feb 1;4(1):171-189. https://doi.org/10.2217/bmm.09.68
Miller, Craig S. ; Foley, Joseph D. ; Bailey, Alison L. ; Campbell, Charles ; Humphries, Roger L. ; Christodoulides, Nicolaos ; Floriano, Pierre N. ; Simmons, Glennon ; Bhagwandin, Bryon ; Jacobson, James W. ; Redding, Spencer W. ; Ebersole, Jeffrey L. ; McDevitt, John T. / Current developments in salivary diagnostics. In: Biomarkers in Medicine. 2010 ; Vol. 4, No. 1. pp. 171-189.
@article{b1e76287085b40f680e145f846f9e7a1,
title = "Current developments in salivary diagnostics",
abstract = "Salivary diagnostics is an emerging field that has progressed through several important developments in the past decade, including the publication of the human salivary proteome and the infusion of federal funds to integrate nanotechnologies and microfluidic engineering concepts into developing compact point-of-care devices for rapid analysis of this secretion. In this article, we discuss some of these developments and their relevance to the prognosis, diagnosis and management of periodontitis, as an oral target, and cardiovascular disease, as a systemic example for the potential of these biodiagnostics. Our findings suggest that several biomarkers are associated with distinct biological stages of these diseases and demonstrate promise as practical biomarkers in identifying and managing periodontal disease, and acute myocardial infarction. The majority of these studies have progressed through biomarker discovery, with the identified molecules requiring more robust clinical studies to enable substantive validation for disease diagnosis. It is predicted that with continued advances in this field the use of a combination of biomarkers in multiplex panels is likely to yield accurate screening tools for these diagnoses in the near future.",
author = "Miller, {Craig S.} and Foley, {Joseph D.} and Bailey, {Alison L.} and Charles Campbell and Humphries, {Roger L.} and Nicolaos Christodoulides and Floriano, {Pierre N.} and Glennon Simmons and Bryon Bhagwandin and Jacobson, {James W.} and Redding, {Spencer W.} and Ebersole, {Jeffrey L.} and McDevitt, {John T.}",
year = "2010",
month = "2",
day = "1",
doi = "10.2217/bmm.09.68",
language = "English (US)",
volume = "4",
pages = "171--189",
journal = "Biomarkers in Medicine",
issn = "1752-0363",
publisher = "Future Medicine Ltd.",
number = "1",

}

TY - JOUR

T1 - Current developments in salivary diagnostics

AU - Miller, Craig S.

AU - Foley, Joseph D.

AU - Bailey, Alison L.

AU - Campbell, Charles

AU - Humphries, Roger L.

AU - Christodoulides, Nicolaos

AU - Floriano, Pierre N.

AU - Simmons, Glennon

AU - Bhagwandin, Bryon

AU - Jacobson, James W.

AU - Redding, Spencer W.

AU - Ebersole, Jeffrey L.

AU - McDevitt, John T.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Salivary diagnostics is an emerging field that has progressed through several important developments in the past decade, including the publication of the human salivary proteome and the infusion of federal funds to integrate nanotechnologies and microfluidic engineering concepts into developing compact point-of-care devices for rapid analysis of this secretion. In this article, we discuss some of these developments and their relevance to the prognosis, diagnosis and management of periodontitis, as an oral target, and cardiovascular disease, as a systemic example for the potential of these biodiagnostics. Our findings suggest that several biomarkers are associated with distinct biological stages of these diseases and demonstrate promise as practical biomarkers in identifying and managing periodontal disease, and acute myocardial infarction. The majority of these studies have progressed through biomarker discovery, with the identified molecules requiring more robust clinical studies to enable substantive validation for disease diagnosis. It is predicted that with continued advances in this field the use of a combination of biomarkers in multiplex panels is likely to yield accurate screening tools for these diagnoses in the near future.

AB - Salivary diagnostics is an emerging field that has progressed through several important developments in the past decade, including the publication of the human salivary proteome and the infusion of federal funds to integrate nanotechnologies and microfluidic engineering concepts into developing compact point-of-care devices for rapid analysis of this secretion. In this article, we discuss some of these developments and their relevance to the prognosis, diagnosis and management of periodontitis, as an oral target, and cardiovascular disease, as a systemic example for the potential of these biodiagnostics. Our findings suggest that several biomarkers are associated with distinct biological stages of these diseases and demonstrate promise as practical biomarkers in identifying and managing periodontal disease, and acute myocardial infarction. The majority of these studies have progressed through biomarker discovery, with the identified molecules requiring more robust clinical studies to enable substantive validation for disease diagnosis. It is predicted that with continued advances in this field the use of a combination of biomarkers in multiplex panels is likely to yield accurate screening tools for these diagnoses in the near future.

UR - http://www.scopus.com/inward/record.url?scp=77951691513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951691513&partnerID=8YFLogxK

U2 - 10.2217/bmm.09.68

DO - 10.2217/bmm.09.68

M3 - Review article

C2 - 20387312

AN - SCOPUS:77951691513

VL - 4

SP - 171

EP - 189

JO - Biomarkers in Medicine

JF - Biomarkers in Medicine

SN - 1752-0363

IS - 1

ER -